Skip to main content
. 2013 Sep 19;17(4):795–802. doi: 10.1017/S1368980013002334

Table 3.

Multivariate linear regression analysis of the associations between serum 25(OH)D category (predictor variable) and fasting glucose, fasting insulin, HOMA-IR, HOMA-β and QUICKI (outcomes); adolescents aged 10–19 years, Korea National Health and Nutrition Examination Survey (KNHANES) 2009–2010

Model 1 Model 2 Model 3 Model 4
Dependent variable β se P value β se P value β se P value β se P value
Total participants (n 1466)
Fasting glucose −0·473 0·245 0·054 −0·462 0·245 0·061 −0·484 0·246 0·050 −0·463 0·245 0·060
Fasting insulin* −0·064 0·014 <0·001 −0·063 0·014 <0·001 −0·067 0·014 <0·001 −0·063 0·013 <0·001
HOMA-IR* −0·069 0·015 <0·001 −0·068 0·014 <0·001 −0·072 0·014 <0·001 −0·068 0·014 <0·001
QUICKI* 0·010 0·002 <0·001 0·010 0·002 <0·001 0·010 0·002 <0·001 0·010 0·002 <0·001
HOMA-β* −0·048 0·015 0·002 −0·047 0·015 0·002 −0·050 0·015 0·001 −0·048 0·015 0·002
HOMA-β† −0·006 0·012 0·629 −0·005 0·012 0·666 −0·005 0·012 0·674 −0·005 0·012 0·673
Lean participants (n 1158)
Fasting insulin* −0·045 0·013 <0·001 −0·044 0·013 0·001 −0·047 0·013 0·001 −0·045 0·013 0·001
HOMA-IR* −0·048 0·014 0·001 −0·047 0·014 0·001 −0·049 0·014 0·001 −0·048 0·014 0·001
QUICKI* 0·007 0·002 0·001 0·007 0·002 0·001 0·007 0·002 0·001 0·007 0·002 0·001
Overweight or obese participants (n 308)
Fasting insulin* −0·149 0·038 <0·001 −0·155 0·036 <0·001 −0·159 0·036 <0·001 −0·154 0·037 <0·001
HOMA-IR* −0·163 0·040 <0·001 −0·170 0·038 <0·001 −0·174 0·037 <0·001 −0·168 0·038 <0·001
QUICKI* 0·022 0·005 <0·001 0·023 0·005 <0·001 0·024 0·005 <0·001 0·023 0·005 <0·001

25(OH)D, 25-hydroxyvitamin D; HOMA-IR, homeostatic model assessment–insulin resistance index; HOMA-β, homeostatic model assessment–β-cell function; QUICKI, quantitative insulin-sensitivity check index.

Multivariate linear regression analyses were performed to assess the association between increasing 25(OH)D category (<37·5 nmol/l, 37·5 to <50 nmol/l, ≥50 nmol/l) and the change in fasting glucose, fasting insulin, HOMA-IR, HOMA-β and QUICKI, after adjustment for potential confounders. If there was an interaction between the three categories of serum 25(OH)D and BMI Z-scores (<85th percentile or ≥85th percentile), we split the group into two (lean v. overweight/obese). The modifying effect of overweight status on the relationship between the three categories of serum 25(OH)D and markers of insulin resistance was significant (test for interaction: P=0·046 for fasting insulin, P = 0·030 for HOMA-IR and P = 0·034 for QUICKI). No significant modifying effect of overweight status on the association between the 25(OH)D categories and fasting glucose or HOMA-β was observed. We entered potential confounders as follows: model 1 included age, sex, physical activity (PA) and BMI Z-score; model 2 included age, sex, PA and fat mass (g) Z-score; model 3 included age, sex, PA and fat mass (%) Z-score; and model 4 included age, sex, PA and fat mass index Z-score.

*The analysis was performed using natural log-transformed values for the dependent variables.

†The analysis was performed after additional adjustment of natural log-transformed HOMA-IR.

HHS Vulnerability Disclosure